You are here:
Gavi’s unique funding model draws heavily on private sector thinking to help overcome the historic limitations to development funding for immunisation
Gavi’s two funding streams, innovative finance and direct contributions account for 25% and 75% respectively of the Vaccine Alliance’s overall funding portfolio.
Multi-year pledges and commitments are crucial to sustaining Gavi's ongoing programmes and its ability to fund new vaccines.
Public-private partnerships Corporations, private individuals & foundations play a vital role in meeting Gavi needs, accounting for 20% of 2000 to 2020 funding.
Cultivation of key public & private donor relationships, co-financing, shaping vaccine markets and mobilising civil society advocacy.
How Gavi is funded
In 2012, approximately 6.6 million children died before the age of five. WHO estimates that 1.5 million of these deaths are due to vaccine-preventable diseases.
16 September 2016
Saving Antibiotics So That Antibiotics Can Save Lives
Wall Street Journal
03 March 2015
Ebola vaccine research in Africa
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2017
modal window here